Boonpheng B, et al. - Via this meta-analysis of 12 cohort studies involving overall 14,673 patients on peritoneal dialysis (PD) (931 autosomal-dominant polycystic kidney disease [ADPKD] and 13,742 non-ADPKD patients), researchers evaluated the risks of mortality, technique failure and peritonitis in ADPKD patients on PD. They identified the relevant studies from MEDLINE, EMBASE and Cochrane databases searched from inception to October 2017. Controls were non-ADPKD patients on PD. Findings revealed 0.68-fold decreased mortality risk among ADPKD patients on PD vs non-ADPKD patients on PD. ADPKD status was not related to the risks of technique failure or peritonitis.